It was observed that the ACTL10 RNA-high expression group had a longer EFS (CN-AML, P=0.014; AML chemotherapy, P<0.0001; log-rank test; Fig. 1) and OS (CN-AML, P=0.0016; AML chemotherapy, P<0.0001; log-rank test; Fig. 1). Here, ACTL10 is linked to acute myeloid leukemia.